Jan 11
Arthritis drugs reduce death rates among sickest COVID-19 patients
Treating critically ill COVID-19 patients with Roche's Actemra or Sanofi's Kevzara arthritis drugs significantly improves survival rates and reduces the amount of time patients need intensive care, study results showed on Thursday. The findings, which have not yet been peer-reviewed,...
Reuters